Differences in Clinical Research Perceptions and Experiences by Age Subgroup.


Journal

Therapeutic innovation & regulatory science
ISSN: 2168-4804
Titre abrégé: Ther Innov Regul Sci
Pays: Switzerland
ID NLM: 101597411

Informations de publication

Date de publication:
01 2020
Historique:
received: 23 07 2018
accepted: 01 11 2018
entrez: 3 2 2020
pubmed: 3 2 2020
medline: 19 5 2021
Statut: ppublish

Résumé

(1) To assess the differing viewpoints of actual and potential adult clinical trial participants in 5 age cohorts, (2) identify misperceptions and opportunities to reduce unnecessary burdens on volunteers, and (3) provide age-specific feedback to study sponsors on their current engagement efforts. Based on 12,427 responses to a global online survey collected between May and July 2017, we conducted a subgroup analysis by age of general clinical research impressions, the participation decision-making process, and experiences of study participants. Overall, younger people were the most misinformed and experienced the most difficulties, while older people had the most misgivings about studies and sponsoring pharmaceutical companies. In the middle years, the desire for compensation peaked. Social media and clinical participation conveniences were important at every life stage. Effectively engaging the public and patients in conversations about clinical research could be achieved via targeted efforts addressing age-specific knowledge gaps, trial-searching behaviors, and displeasing aspects of trial participation. The altruistic benefits of participation, and involvement of patients' personal physicians, resonate particularly well across multiple age cohorts. Social media and other technologies are underutilized, especially among older populations.

Sections du résumé

BACKGROUND
(1) To assess the differing viewpoints of actual and potential adult clinical trial participants in 5 age cohorts, (2) identify misperceptions and opportunities to reduce unnecessary burdens on volunteers, and (3) provide age-specific feedback to study sponsors on their current engagement efforts.
METHODS
Based on 12,427 responses to a global online survey collected between May and July 2017, we conducted a subgroup analysis by age of general clinical research impressions, the participation decision-making process, and experiences of study participants.
RESULTS
Overall, younger people were the most misinformed and experienced the most difficulties, while older people had the most misgivings about studies and sponsoring pharmaceutical companies. In the middle years, the desire for compensation peaked. Social media and clinical participation conveniences were important at every life stage.
CONCLUSIONS
Effectively engaging the public and patients in conversations about clinical research could be achieved via targeted efforts addressing age-specific knowledge gaps, trial-searching behaviors, and displeasing aspects of trial participation. The altruistic benefits of participation, and involvement of patients' personal physicians, resonate particularly well across multiple age cohorts. Social media and other technologies are underutilized, especially among older populations.

Identifiants

pubmed: 32008250
doi: 10.1007/s43441-019-00033-1
pii: 10.1007/s43441-019-00033-1
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-102

Auteurs

Annick Anderson (A)

The Center for Information and Study on Clinical Research Participation (CISCRP), One Liberty Square, Suite 510, Boston, MA, 02109, USA. annickanderson@ciscrp.org.

Deborah Borfitz (D)

The Center for Information and Study on Clinical Research Participation (CISCRP), One Liberty Square, Suite 510, Boston, MA, 02109, USA.

Kenneth Getz (K)

The Center for Information and Study on Clinical Research Participation (CISCRP), One Liberty Square, Suite 510, Boston, MA, 02109, USA.
Tufts University School of Medicine, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH